The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression

E-cadherin complexes with the actin cytoskeleton via cytoplasmic catenins and maintains the functional characteristics and integrity of the epithelia in normal epithelial tissues. Lost expression of E-cadherin disrupts this complex resulting in loss of cell polarity, epithelial denudation and increased epithelial permeability in a variety of tissues. Decreased expression of E-cadherin has also been observed in invasive and metastatic human tumors. In this study, we investigated the effect of E-cadherin loss in prostatic epithelium using newly developed genetically engineered mouse models. Deletion of E-cadherin in prostatic luminal epithelial cells with modified probasin promoter driven Cre (PB-Cre4) induced the development of mouse prostatic intraepithelial neoplasia (PIN). An increase in levels of cytoplasmic and nuclear β-catenin appeared in E-cadherin deleted atypical cells within PIN lesions. Using various experimental approaches, we further demonstrated that the knockdown of E-cadherin expression elevated free cytoplasmic and nuclear β-catenin and enhanced androgen-induced transcription and cell growth. Intriguingly, pathological changes representing prostatic epithelial cell denudation and increased apoptosis accompanied the above PIN lesions. The essential role of E-cadherin in maintaining prostatic epithelial integrity and organization was further demonstrated using organoid culture approaches. To directly assess the role of loss of E-cadherin in prostate tumor progression, we generated a new mouse model with bigenic Cdh1 and Pten deletion in prostate epithelium. Early onset, aggressive tumor phenotypes presented in the compound mice. Strikingly, goblet cell metaplasia was observed, intermixed within prostatic tumor lesions of the compound mice. This study provides multiple lines of novel evidence demonstrating a comprehensive role of E-cadherin in maintaining epithelial integrity during the course of prostate oncogenic transformation, tumor initiation and progression.

[1]  Zijie Sun,et al.  A pivotal role of androgen signaling in Notch-responsive cells in prostate development, maturation, and regeneration. , 2019, Differentiation; research in biological diversity.

[2]  R. Cardiff,et al.  Deletion of the p16INK4a tumor suppressor and expression of the androgen receptor induce sarcomatoid carcinomas with signet ring cells in the mouse prostate , 2019, PloS one.

[3]  Zijie Sun,et al.  Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate , 2018, The Journal of Biological Chemistry.

[4]  B. Lambrecht,et al.  Characterization of a lung epithelium specific E-cadherin knock-out model: Implications for obstructive lung pathology , 2018, Scientific Reports.

[5]  Zijie Sun,et al.  An Indispensable Role of Androgen Receptor in Wnt Responsive Cells During Prostate Development, Maturation, and Regeneration , 2018, Stem cells.

[6]  W. Xue,et al.  E-cadherin bridges cell polarity and spindle orientation to ensure prostate epithelial integrity and prevent carcinogenesis in vivo , 2018, bioRxiv.

[7]  T. D’alfonso,et al.  Current Concepts in Diagnosis, Molecular Features, and Management of Lobular Carcinoma In Situ of the Breast With a Discussion of Morphologic Variants. , 2017, Archives of pathology & laboratory medicine.

[8]  L. Wessels,et al.  PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma , 2016, Cell reports.

[9]  M. Shen,et al.  Basal Progenitors Contribute to Repair of the Prostate Epithelium Following Induced Luminal Anoikis , 2016, Stem cell reports.

[10]  R. Luong,et al.  Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice , 2016, PloS one.

[11]  Hans Clevers,et al.  Organoid culture systems for prostate epithelial tissue and prostate cancer tissue , 2016, Nature Protocols.

[12]  R. Nusse,et al.  Wnt/β‐Catenin‐Responsive Cells in Prostatic Development and Regeneration , 2015, Stem cells.

[13]  Jamie R. Kutasovic,et al.  Invasive lobular carcinoma of the breast: morphology, biomarkers and ’omics , 2015, Breast Cancer Research.

[14]  R. Luong,et al.  Crosstalking between Androgen and PI3K/AKT Signaling Pathways in Prostate Cancer Cells* , 2014, The Journal of Biological Chemistry.

[15]  M. Karin,et al.  Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis , 2014, Proceedings of the National Academy of Sciences.

[16]  Zijie Sun,et al.  Identification of a Novel Role of ZMIZ2 Protein in Regulating the Activity of the Wnt/β-Catenin Signaling Pathway* , 2013, The Journal of Biological Chemistry.

[17]  A. Frampton,et al.  Gene of the month: E-cadherin (CDH1) , 2013, Journal of Clinical Pathology.

[18]  Gerald C. Chu,et al.  Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee. , 2013, Cancer research.

[19]  R. Luong,et al.  Conditional Deletion of the Pten Gene in the Mouse Prostate Induces Prostatic Intraepithelial Neoplasms at Early Ages but a Slow Progression to Prostate Tumors , 2013, PloS one.

[20]  E. Walker,et al.  E-cadherin is required for intestinal morphogenesis in the mouse. , 2012, Developmental biology.

[21]  Zijie Sun,et al.  ZMIZ1 Preferably Enhances the Transcriptional Activity of Androgen Receptor with Short Polyglutamine Tract , 2011, PloS one.

[22]  J. McKenney,et al.  Conditional Expression of the Androgen Receptor Induces Oncogenic Transformation of the Mouse Prostate* , 2011, The Journal of Biological Chemistry.

[23]  D. Thedens,et al.  Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer. , 2011, The American journal of pathology.

[24]  E. Wolf,et al.  A Key Role for E-cadherin in Intestinal Homeostasis and Paneth Cell Maturation , 2010, PloS one.

[25]  G. Berx,et al.  The cell-cell adhesion molecule E-cadherin , 2008, Cellular and Molecular Life Sciences.

[26]  L. Luo,et al.  A global double‐fluorescent Cre reporter mouse , 2007, Genesis.

[27]  Zijie Sun,et al.  LZTS2 Is a Novel β-Catenin-Interacting Protein and Regulates the Nuclear Export of β-Catenin , 2006, Molecular and Cellular Biology.

[28]  Zijie Sun,et al.  Roles and regulation of Wnt signaling and β-catenin in prostate cancer , 2006 .

[29]  B. Gumbiner,et al.  Regulation of cadherin-mediated adhesion in morphogenesis , 2005, Nature Reviews Molecular Cell Biology.

[30]  Zijie Sun,et al.  Beta-catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor. , 2005, Molecular endocrinology.

[31]  P. Nelson,et al.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. , 2003, Cancer cell.

[32]  W. Isaacs,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Pathological and Molecular Aspects of Prostate Cancer Prostate Cancer Ii , 2022 .

[33]  Zijie Sun,et al.  Phosphatidylinositol 3-Kinase/Akt Stimulates Androgen Pathway through GSK3β Inhibition and Nuclear β-Catenin Accumulation* , 2002, The Journal of Biological Chemistry.

[34]  R. Kemler,et al.  E-cadherin is a survival factor for the lactating mouse mammary gland , 2002, Mechanisms of Development.

[35]  Kenneth Pienta,et al.  APC/CTNNB1 (β‐catenin) pathway alterations in human prostate cancers , 2002 .

[36]  Elaine Fuchs,et al.  Intercellular adhesion, signalling and the cytoskeleton , 2002, Nature Cell Biology.

[37]  D. Longo,et al.  Linking β-Catenin to Androgen-signaling Pathway* , 2002, The Journal of Biological Chemistry.

[38]  A. Consiglio,et al.  A new-generation stable inducible packaging cell line for lentiviral vectors. , 2001, Human gene therapy.

[39]  D. Laurents,et al.  The cadherin cytoplasmic domain is unstructured in the absence of beta-catenin. A possible mechanism for regulating cadherin turnover. , 2001, The Journal of biological chemistry.

[40]  L. Chung,et al.  Regions of Prostate-specific Antigen (PSA) Promoter Confer Androgen-independent Expression of PSA in Prostate Cancer Cells* , 2000, The Journal of Biological Chemistry.

[41]  D. Longo,et al.  Truncation of the extracellular region abrogrates cell contact but retains the growth-suppressive activity of E-cadherin. , 2000, Cancer research.

[42]  W. Isaacs,et al.  Detection and analysis of β‐catenin mutations in prostate cancer , 2000 .

[43]  E. Gelmann,et al.  Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. , 2000, Cancer research.

[44]  P. Polakis.  Wnt signaling and cancer. , 2000, Genes & development.

[45]  G. Stamp,et al.  Phenotypic and genotypic characterization of commonly used human prostatic cell lines , 2000, BJU international.

[46]  D. Trono,et al.  A Third-Generation Lentivirus Vector with a Conditional Packaging System , 1998, Journal of Virology.

[47]  Kylie L. Gorringe,et al.  Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. , 1998, Cancer research.

[48]  E. Gelmann,et al.  β-Catenin Mutations in Human Prostate Cancer , 1998 .

[49]  Anthony E. Reeve,et al.  E-cadherin germline mutations in familial gastric cancer , 1998, Nature.

[50]  W. Isaacs,et al.  Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. , 1998, Cancer research.

[51]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[52]  W. Isaacs,et al.  The cadherin cell-cell adhesion pathway in prostate cancer progression. , 1997, British journal of urology.

[53]  J. Trapman,et al.  Two Androgen Response Regions Cooperate in Steroid Hormone Regulated Activity of the Prostate-specific Antigen Promoter (*) , 1996, The Journal of Biological Chemistry.

[54]  J. Herman,et al.  E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. , 1995, Cancer research.

[55]  L. Larue,et al.  E-cadherin null mutant embryos fail to form a trophectoderm epithelium. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[56]  W. Isaacs,et al.  Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. , 1992, Cancer research.

[57]  M. Quintanilla,et al.  A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis , 1991, The Journal of cell biology.

[58]  M. G. Oliver,et al.  Functional biology of intestinal goblet cells. , 1991, The American journal of physiology.

[59]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[60]  E. Gelmann,et al.  Beta-catenin mutations in human prostate cancer. , 1998, Cancer research.

[61]  W. Birchmeier,et al.  Adherens junction proteins in tumour progression. , 1995, Cancer surveys.